english.prescrire.org > Spotlight > "Spotlight"
"Spotlight"

Impending changes to European pharmaceutical regulations: part II

 ADVANCING HEALTHCARE POLICY  In order to prepare its new "Pharmaceutical Strategy for Europe", the European Commission organised several public consultations in advance. The present article reproduces extensive excerpts from a report published by the European Parliamentary Research Service, produced in connection with these consultations, which calls for the creation of a "European Medicines Infrastructure".
Full article (3 pages) available for free download

  • The report published by the European Parliamentary Research Service analyses the strengths and weaknesses of the current pharmaceutical research and development (R&D) model in Europe. It then proposes a new approach to pharmaceutical policy, including the creation of a Europe-­wide public R&D infrastructure.
     
  • Future Prescrire articles will address the announced revisions of the EU's general pharmaceutical legislation and legislation on rare diseases and paediatric drugs.

©Prescrire 1 January 2023

Source: "Impending changes to European pharmaceutical regulations: part II" Prescrire International 2023; 32 (244): 23-25. Free.

Enjoy full access to Prescrire International, and support independent information